Table 2.

Baseline and end of treatment RDQ scores (ITT population)

RDQ dimension score	Gaviscon DA (n = 536)	Placebo (n = 537)
GERD (combined heartburn and regurgitation)
Baseline score	2.51 (0.93)	2.50 (0.94)
Range of scores	0.0–5.0	0.0–5.0
Post‐treatment score	1.25 (0.94)	1.46 (1.00)
Range of scores	0.0–4.9	0.0–4.5
Min/max score change from baseline	−4.6–1.5	−4.0–1.4
Heartburn
Baseline score	2.37 (1.33)	2.30 (1.35)
Range of scores	0.0–5.0	0.0–5.0
Post‐treatment score	1.20 (1.15)	1.38 (1.24)
Range of scores	0.0–5.0	0.0–5.0
Min/max score change from baseline	−4.5–2.5	−4.5–2.0
Regurgitation
Baseline score	2.65 (1.26)	2.70 (1.25)
Range of scores	0.0–5.0	0.0–5.0
Post‐treatment score	1.30 (1.13)	1.54 (1.21)
Range of scores	0.0–5.0	0.0–5.0
Min/max score change from baseline	−5.0, 1.0	−4.5–2.5
Dyspepsia
Baseline score	2.02 (1.39)	2.02 (1.36)
Range of scores	0.0–5.0	0.0–5.0
Post‐treatment score	1.04 (1.10)	1.22 (1.14)
Range of scores	0.0–5.0	0.0–5.0
Min/max score change from baseline	−5.0–2.8	−5.0–2.3

RDQ, reflux disease questionnaire; ITT, intent‐to‐treat; DA, Double Action; GERD, gastroesophageal reflux disease.